Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2 [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating safety and efficacy of EXE844 Otic Suspension for otitis media at tympanostomy tube insertion has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXE844 Otic Suspension (EXE844)

Snippet

Sponsor: Alcon Research | Conditions: Otitis Media With Effusion in Children, Otitis Media Recurrent | Phase 3 | Status: COMPLETED | Results posted: 2017-08-28